Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ipca Laborator Ipca Laboratories Ltd. | BSE 1457.40 -7.15 (-0.49%) | NSE 1449.80 -14.10 (-0.96%) | Trade | Add

BSE Live

Feb 20, 16:01

1457.40 -7.15 (-0.49%)

Volume

AVERAGE VOLUME

5-Day

92,682

10-Day

90,541

30-Day

58,763

115,438

Prev. Close

1464.55
Open Price

1461.20

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Feb 20, 15:59

1449.80 -14.10 (-0.96%)

Volume

AVERAGE VOLUME

5-Day

210,327

10-Day

184,200

30-Day

207,900

93,974

Prev. Close

1463.90
Open Price

1460.00

Bid Price (Qty.)
1449.80 (9)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Ipca Laboratories (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	4,307.29	3,579.65	3,168.04	3,094.70	2,803.79
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	25.81	56.01	39.40
Revenue From Operations [Net]	4,307.29	3,579.65	3,142.23	3,038.69	2,764.39
Total Operating Revenues	4,367.43	3,633.15	3,193.40	3,102.21	2,803.66
Other Income	64.69	54.59	39.54	20.65	27.67
Total Revenue	4,432.12	3,687.74	3,232.94	3,122.86	2,831.33
EXPENSES
Cost Of Materials Consumed	1,431.10	1,098.02	923.20	947.31	886.01
Purchase Of Stock-In Trade	204.65	167.87	168.30	161.84	138.33
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-155.05	-106.14	20.98	-1.73	22.26
Employee Benefit Expenses	870.79	752.24	712.78	674.93	603.35
Finance Costs	15.79	18.49	24.02	23.34	28.60
Depreciation And Amortisation Expenses	178.69	171.88	174.36	171.00	161.23
Other Expenses	1,101.18	1,027.99	926.50	887.97	880.10
Total Expenses	3,647.15	3,130.35	2,950.14	2,864.66	2,719.88
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	784.97	557.39	282.80	258.20	111.45
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	784.97	557.39	282.80	258.20	111.45
Tax Expenses-Continued Operations
Current Tax	137.98	119.90	60.01	56.95	21.64
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-5.47	-12.40	-9.98	13.00	-2.71
Tax For Earlier Years	0.00	-5.02	-0.34	-0.04	0.00
Total Tax Expenses	132.51	102.48	49.69	69.91	18.93
Profit/Loss After Tax And Before ExtraOrdinary Items	652.46	454.91	233.11	188.29	92.52
Profit/Loss From Continuing Operations	652.46	454.91	233.11	188.29	92.52
Profit/Loss For The Period	652.46	454.91	233.11	188.29	92.52
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	51.64	36.01	18.47	14.92	7.33
Diluted EPS (Rs.)	51.60	36.01	18.47	14.92	7.33
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	257.80
Indigenous Raw Materials	0.00	0.00	0.00	0.00	472.84
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	4.44
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	28.66
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	101.08	12.64	12.62	0.00	12.62
Tax On Dividend	20.77	2.60	2.56	0.00	2.57
Equity Dividend Rate (%)	250.00	150.00	50.00	50.00	0.00